2025-01-17 07:50:04
LISCure Biosciences received clinical approval for two microbiome programs targeting autoimmune disease and NASH
Health/ 2023-07-22
LISCure Biosciences received clinical ap...

SEOUL,South Korea,Sept. 30,2021-- LISCure Biosciences ("LISCure") announced that it has received approval for a global phase 1 cli...

Clarity and Evergreen enter Targeted Copper Theranostics manufacturing agreement for US Clinical trials
Corporate/ 2023-07-23
Clarity and Evergreen enter Targeted Cop...

SYDNEY,Sept. 30,2021-- Clarity Pharmaceuticals(ASX: CU6) ("Clarity"),an Australian-based clinical stage radiopharmaceutical compan...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release